Mechanism and structure-activity relationships of norspermidine-based peptidic inhibitors of trypanothione reductase

被引：21

作者：

Dixon, MJ ^{[1
]}

Maurer, RI ^{[1
]}

Biggi, C ^{[1
]}

Oyarzabal, J ^{[1
]}

Essex, JW ^{[1
]}

Bradley, M ^{[1
]}

机构：

[1] Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2005年 / 13卷 / 14期

基金：

英国生物技术与生命科学研究理事会; 英国工程与自然科学研究理事会;

关键词：

trypanothione reductase; parallel synthesis; mechanism of action; structure-activity relationships;

D O I：

10.1016/j.bmc.2005.04.039

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A library of polyamine-peptide conjugates based around some previously identified inhibitors of trypanothione reductase was synthesised by parallel solid-phase chemistry and screened. Kinetic analysis of library members established that subtle structural changes altered their mechanism of action, switching between competitive and non-competitive inhibition. The mode of action of the non-competitive inhibitors was investigated in detail by a variety of techniques including enzyme kinetic analysis (looking at both NADPH and trypanothione disulfide substrates), gel filtration chromatography and analytical ultracentrifugation, leading to the identification of an allosteric mode of inhibition. (c) 2005 Published by Elsevier Ltd.

引用

页码：4513 / 4526

页数：14

共 50 条

[41] Structure-activity relationships of carbocyclic influenza neuraminidase inhibitors
Williams, MA
Lew, W
Mendel, DB
Tai, CY
Escarpe, PA
Laver, WG
Stevens, RC
Kim, CU
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (14) : 1837 - 1842
[42] Structure-activity relationships of novel potent MurF inhibitors
Gu, YG
Florjancic, AS
Clark, RF
Zhang, TY
Cooper, CS
Anderson, DD
Lerner, CG
McCall, JO
Cai, YN
Black-Schaefer, CL
Stamper, GF
Hajduk, PJ
Beutel, BA
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) : 267 - 270
[43] The development of novel telomerase inhibitors: Structure-activity relationships
Cheng, MK
Modi, C
Grindon, CR
Stevens, MFG
Laughton, CA
BRITISH JOURNAL OF CANCER, 2003, 88 : S40 - S40
[44] Structure-activity relationships of PDE5 inhibitors
Eros, D.
Szantai-Kis, Cs.
Kiss, R.
Keri, Gy.
Hegymegi-Barakonyi, B.
Koevesdi, I.
Orfi, L.
CURRENT MEDICINAL CHEMISTRY, 2008, 15 (16) : 1570 - 1585
[45] Structure-activity relationships of some complex I inhibitors
Miyoshi, H
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1998, 1364 (02): : 236 - 244
[46] STRUCTURE-ACTIVITY RELATIONSHIPS OF MONOAMINE-OXIDASE INHIBITORS
FUJITA, T
JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (08) : 923 - 930
[47] Structure - activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors
Sun, Xicheng
Qiu, Jian
Strong, Sarah A.
Green, Louis S.
Wasley, Jan W. F.
Colagiovanni, Dorothy B.
Mutka, Sarah C.
Blonder, Joan P.
Stout, Adam M.
Richards, Jane P.
Chun, Lawrence
Rosenthal, Gary J.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
[48] Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis
Lu, Guo-Liang
Tong, Amy S. T.
Conole, Daniel
Sutherland, Hamish S.
Choi, Peter J.
Franzblau, Scott G.
Upton, Anna M.
Lotlikar, Manisha U.
Cooper, Christopher B.
Denny, William A.
Palmer, Brian D.
BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (22)
[49] Structure-Activity Relationships of Novel Tryptamine-Based Inhibitors of Bacterial Transglycosylase
Sosic, Izidor
Anderluh, Marko
Sova, Matej
Gobec, Martina
Rascan, Irena Mlinarisc
Derouaux, Adeline
Amoroso, Ana
Terrak, Mohammed
Breukink, Eefjan
Gobec, Stanislav
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (24) : 9712 - 9721
[50] Structure-activity relationships in thiophene-based SHIP2 inhibitors
Kellum, Brittni M.
Kerr, William G.
Chisholm, John D.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243

← 1 2 3 4 5 →